Design and production of dengue virus chimeric proteins useful for developing tetravalent vaccines.

Vaccine(2020)

Cited 2|Views7
No score
Abstract
Dengue virus (DENV) is a Flavivirus estimated to cause 390 million infections/year. Currently, there is no anti-viral specific treatment for dengue, and efficient DENV vector control is still unfeasible. Here, we designed and produced chimeric proteins containing potential immunogenic epitopes from the four DENV serotypes in an attempt to further compose safer, balanced tetravalent dengue vaccines.
More
Translated text
Key words
Dengue,Tetravalent vaccine,Chimeric proteins
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined